More relapsing multiple sclerosis (MS) patients given ublituximab remained relapse-free over the two-year long Phase 3 ULTIMATE clinical trials, compared to those…
Articles by Marisa Wexler, MS
There is minimal data available on the safety of most disease-modifying therapies for multiple sclerosis (MS) when used during…
Repeat harvesting of bone marrow cells and infusing them back into the bloodstream is safe and feasible in people with…
People newly diagnosed with multiple sclerosis (MS) in Norway have in recent years received disease-modifying therapies (DMTs) independent…
The National Institute for Health and Care Excellence (NICE) has added oral Vumerity (diroximel fumarate), approved to treat relapsing-remitting multiple…
An intervention that involves training to recognize facial expressions, and also mimicking these expressions, may help people with multiple…
Electrically stimulating certain regions of the brain may help to ease tremors in people with multiple sclerosis (MS), but…
Many people with multiple sclerosis (MS) report new bouts of depression and anxiety as a result of the COVID-19…
NVG-291, an experimental therapy designed to promote nervous system repair, has so far been well tolerated in an ongoing Phase…
Nearly three of every four participants in the CONSONANCE clinical trial, which is evaluating Ocrevus (ocrelizumab) in people with…
Treatment with Kesimpta (ofatumumab) for more than three years revealed no new or unexpected safety findings, and continued to…
Ublituximab, an experimental therapy for relapsing multiple sclerosis (MS) patients, outperformed Aubagio on a number of disability-related outcomes…
Infection with the herpes simplex virus does not increase the risk of multiple sclerosis (MS), according to a new…
The MS Society of Canada is providing thousands in funding to 66 research projects that aim to accelerate scientific…
A four-protein complex, or tetramer, of the protein STAT5 is involved in the development of multiple sclerosis (MS)-like autoimmune…
Treatment with cannabis-based medications may ease muscle spasms, decrease pain, and aid in sleep for people with multiple sclerosis…
A measure of the nose’s sensitivity to smell could be used to detect whether treatments for relapsing multiple sclerosis…
Among healthcare providers in the U.K., considerable variation exists in marking the transition from relapsing-remitting multiple sclerosis (RRMS) to…
Getting the Bacillus Calmette-Guerin (BCG) vaccine to protect against tuberculosis (TB) — an immunization often given to infants and small…
Initial treatment with Novantrone (mitoxantrone) can reduce the risk of relapses and worsening disability in people with highly active…
While people who smoke cigarettes are more likely to be diagnosed with multiple sclerosis, MS patients who are daily…
A substantial amount of disability worsening happens independently of relapses in people with multiple sclerosis (MS), including those in…
Roche is teaming up with the University of Plymouth in the U.K. to help develop Floodlight MS, the company’s…
Immune system reaction to casein, a protein in cow’s milk, can trigger an inflammatory neurological disease in mice that’s similar…
Measuring levels of the neurofilament light chain (NfL) protein in blood may be a way to “quantify” relapse severity and…
Electrically stimulating the brain while doing at-home cognitive training games can help to prevent a decline in cognition for people…
Tolebrutinib, an investigative inhibitor of Bruton’s tyrosine kinase (BTK) being developed by Sanofi to treat all forms of multiple sclerosis…
Using a two-step machine learning strategy, researchers have developed an algorithm to predict the risk of multiple sclerosis (MS)…
Hormonal changes over time — and especially those around menopause — are often associated with disability worsening in multiple…
The experimental medication ublituximab significantly reduces the number of new brain lesions with severe nerve cell degeneration in people…